Stocktoria
Mineralys Therapeutics, Inc. MLYS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-02-10
Mineralys Therapeutics, Inc. statistics & valuation
Market cap$2.4B
P / B3.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -23.4% | -86.4% | -28.6% | -26.0% |
| Return on equity | -23.9% | -93.0% | -29.8% | 57.0% |
| Current ratio | 43.76 | 14.02 | 23.76 | 13.98 |
Source: SEC EDGAR filings · CIK 0001933414 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.